Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 10,874 | 13,761 | 13,229 | 13,810 | 11,010 |
| Cost of Goods | 6,921 | 8,358 | 7,624 | 8,154 | 7,366 |
| Gross Profit | 3,953 | 5,403 | 5,605 | 5,656 | 3,644 |
| Operating Expenses | 8,950 | 9,875 | 9,377 | 9,197 | 8,323 |
| Operating Income | -4,076 | -4,114 | -3,148 | -3,387 | -4,313 |
| Interest Expense | -9 | 0 | 0 | 0 | 0 |
| Other Income | -1 | -279 | 42 | -109 | 88 |
| Pre-tax Income | -4,068 | -4,393 | -3,106 | -3,496 | -4,225 |
| Income Tax | 40 | 34 | 40 | 37 | 40 |
| Net Income Continuous | -4,108 | -4,427 | -3,146 | -3,533 | -4,265 |
| Net Income | $-4,108 | $-4,427 | $-3,146 | $-3,533 | $-4,265 |
| EPS Basic Total Ops | -750.00 | -875.00 | -1,125.00 | -750.00 | -875.00 |
| EPS Basic Continuous Ops | -759.81 | -821.91 | -671.64 | -758.06 | -915.58 |
| EPS Diluted Total Ops | -750.00 | -875.00 | -1,125.00 | -750.00 | -875.00 |
| EPS Diluted Continuous Ops | -759.81 | -821.91 | -671.64 | -758.06 | -915.58 |
| EBITDA(a) | $-3,786 | $-3,842 | $-2,860 | $-3,111 | $-4,101 |